The first patent for Effient is currently set to expire in September 2012, although Eli Lilly and Company holds the exclusive rights to make this drug in the United States until at least July 2014. This is the earliest predictable date that a generic version of Effient could become available.
- Effient Information for Consumers
- Effient Information for Healthcare Professionals (includes dosage details)
- Side Effects of Effient (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 11 Mar 2014 • 2 answers
Posted 13 Sep 2015 • 2 answers
Posted 13 Dec 2015 • 0 answers
Posted 26 Sep 2016 • 0 answers
Posted 27 Oct 2016 • 1 answer